Are patient outcomes improved by surgery that uses a glowing dye to illuminate a cancerous tumour?
Sarcomas are rare cancers affecting the bones and soft tissues. Surgery is the main treatment, with the aim of removing the entire tumour. However, it can be hard for surgeons to see where the tumour ends and healthy tissue begins. Leaving any cancer cells behind increases the risk of the cancer returning. This trial, called SarcoSIGHT, looks at a technique called fluorescence-guided surgery. Patients are randomly put into one of two groups. One group has standard surgery. The other group receives an injection of a safe dye called indocyanine green (ICG) before their operation. This dye makes the tumour glow under a special infrared camera, helping guide the surgeon. The trial is open to people of all ages across the UK who are having surgery to cure an intermediate or high-grade sarcoma. It aims to find out if this glowing dye leads to cleaner surgical results.
At a glance
What is this study about?
Sarcomas are uncommon cancers that develop in the bones and soft tissues, such as muscles, nerves, and fat. In the UK, about 5,300 people are diagnosed with a sarcoma each year. Surgery is usually the most important step in treating them, with doctors aiming to take out all the cancer cells while keeping as much healthy tissue as possible.
During surgery, telling the difference between a tumour and normal tissue using just sight and touch can be very challenging. After the operation, specialists check the edges of the removed tissue under a microscope. If cancer cells are found right at the edge, it means some cancer may have been left behind. This increases the chance of the cancer coming back and can lower the chances of long-term recovery.
To help surgeons see tumours more clearly, researchers are testing a technique called fluorescence-guided surgery. Patients in this study receive an injection of a medical dye called indocyanine green (ICG) into a vein before their operation. The tumour absorbs this dye. During the operation, the surgeon uses a special near-infrared camera that makes the tumour light up on a screen in real time.
The SarcoSIGHT trial aims to find out if using this glowing dye helps surgeons remove sarcomas more cleanly compared to standard surgery. By comparing both approaches, the study team hopes to improve surgical treatments and overall outcomes for future sarcoma patients in the NHS.
Key takeaways
- The trial compares standard sarcoma surgery against surgery using a glowing dye (ICG).
- A special camera makes the dye glow, helping surgeons spot the boundaries between tumour and healthy tissue.
- The study is open to UK patients of all ages with intermediate or high-grade bone or soft tissue sarcomas.
- Participants are randomly chosen to receive either the glowing dye surgery or standard surgery.
- Taking part involves filling in brief quality-of-life surveys from home for up to one year after surgery.
Who may be eligible?
This trial is open to patients of any age who have been diagnosed with an intermediate or high-grade sarcoma in their bones or soft tissues. To take part, your planned surgery must be intended to completely remove the cancer and cure the condition.
You will not be able to join the study if your sarcoma has come back after previous treatment, or if the surgery is only meant to relieve symptoms rather than cure the cancer. People whose tumours are located inside the brain, abdomen, or internal organs are also not eligible.
Additionally, you cannot take part if you are pregnant or breastfeeding, or if you have known allergies to iodine, shellfish, or the ICG dye. People with certain thyroid problems, such as an overactive thyroid, are also excluded for safety reasons.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I have been diagnosed with an intermediate or high-grade bone or soft tissue sarcoma.
- My planned surgery aims to cure the cancer by removing the tumour completely.
- This is a new tumour and has not returned from a previous cancer.
- My tumour is not located in my brain, abdomen, or internal organs.
- I do not have an allergy to iodine, shellfish, or indocyanine green (ICG) dye.
- I am not currently pregnant or breastfeeding.
What does participation involve?
If you agree to take part, a computer will randomly assign you to one of two groups. You have an equal chance of being in either group, and both you and your doctor will know which group you are in.
If you are in the glowing dye group, you will come to the hospital 12 to 24 hours before your operation to receive the dye through a simple injection into a vein. During your surgery, the surgical team will use the infrared camera alongside their usual techniques. If you are in the standard group, you will have the usual operation without the dye, arriving at the hospital either the day before or the morning of surgery as normal.
After your operation, your medical care and recovery will be exactly the same as for any patient having sarcoma surgery. To see how you are getting on, the research team will ask you to fill in short quality-of-life questionnaires before surgery, and then at 1, 3, 6, and 12 months afterwards. These questionnaires take about 10 to 15 minutes each and can be completed online from home, meaning no extra hospital visits are needed.
Potential risks and benefits
Locations (17)
- The Newcastle upon Tyne Hospitals NHS Foundation TrustCity onlyNewcastle upon Tyne, England
- Manchester University NHS Foundation TrustCity onlyManchester, England
- The Royal Orthopaedic Hospital NHS Foundation TrustCity onlyBirmingham, England
- Royal National Orthopaedic Hospital NHS TrustCity onlyStanmore, England
- Sheffield Teaching Hospitals NHS Foundation TrustCity onlySheffield, England
- Nottingham University Hospitals NHS TrustUnverifiedNottingham, England
- North Bristol NHS TrustUnverifiedBristol, England
- University Hospitals Plymouth NHS TrustUnverifiedPlymouth, England
- Royal Devon University Healthcare NHS Foundation TrustUnverifiedExeter, England
- The Royal Marsden HospitalUnverifiedLondon, England
- The Christie NHS Foundation TrustUnverifiedManchester, England
- Swansea Bay University Local Health BoardUnverifiedPort Talbot, Wales
Common questions
What is the dye and will it make my whole body glow?
The dye is called indocyanine green (ICG). It does not glow in normal light and will not make you glow in the dark. It can only be seen on a monitor when viewed through a special near-infrared camera in the operating theatre.
Is the glowing dye safe?
Yes, ICG has been used safely in routine medical procedures and eye tests for many years. Serious side effects are very rare, though it should not be used in people with iodine or shellfish allergies.
Can I choose which surgical group I am in?
No. A computer assigns you to a group by chance. This process, called randomisation, makes sure the results are fair and scientifically reliable.
Will taking part mean more hospital visits?
If you are in the dye group, you will need to come to the hospital the day before surgery for your injection. Aside from this, follow-up questionnaires can be done from home, and your clinic visits will follow your normal post-surgery routine.
What happens if I change my mind?
You can leave the trial at any point, even after agreeing to take part. You do not need to give a reason, and deciding to leave will not affect your routine cancer care in any way.
How to find out more
- Newcastle Clinical Trials Unit
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.